EE+ POEM Archive
Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support
Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Tocilizumab and Sarilumab Are Effective for Critically Ill Patients With COVID-19 Who Require Organ Support." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315324/all/Tocilizumab_and_sarilumab_are_effective_for_critically_ill_patients_with_COVID_19_who_require_organ_support.
Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315324/all/Tocilizumab_and_sarilumab_are_effective_for_critically_ill_patients_with_COVID_19_who_require_organ_support. Accessed March 27, 2023.
Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315324/all/Tocilizumab_and_sarilumab_are_effective_for_critically_ill_patients_with_COVID_19_who_require_organ_support
Tocilizumab and Sarilumab Are Effective for Critically Ill Patients With COVID-19 Who Require Organ Support [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315324/all/Tocilizumab_and_sarilumab_are_effective_for_critically_ill_patients_with_COVID_19_who_require_organ_support.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support
ID - 1315324
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315324/all/Tocilizumab_and_sarilumab_are_effective_for_critically_ill_patients_with_COVID_19_who_require_organ_support
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
